| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2008385 | Peptides | 2008 | 10 Pages |
Abstract
Many types of bioactive peptides that inhibit angiotensin I, angiotensin I converting enzyme (ACE) and Ang II type 1 receptor (AT1) in the cardiovascular system contribute to the prevention and treatment of hypertension. These inhibitory peptides are derived from many food proteins or artificial synthetic products. Further research examining the bioavailability of ACE inhibitory peptides will lead to the development of more effective ACE inhibitory peptides and foods. Our research also demonstrates that ACE inhibitory peptide LAP may lower blood pressure with no adverse effects.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Fang Hong, Luo Ming, Sheng Yi, Li Zhanxia, Wu Yongquan, Liu Chi,